Chugai Pharm ADR (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 2,018,490 | 1,449,552 | N/A | N/A |
| Depreciation Amortization | 285,534 | 242,889 | N/A | N/A |
| Other Working Capital | -605,557 | 57,086 | N/A | N/A |
| Other Operating Activity | 228,862 | 151,570 | 0 | 0 |
| Operating Cash Flow | $1,927,329 | $1,901,097 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -346,146 | -182,776 | N/A | N/A |
| PPE Investments | -536,383 | -486,588 | N/A | N/A |
| Purchase Of Investment | -1,664 | -9,320 | N/A | N/A |
| Purchase Sale Intangibles | -40,881 | -75,146 | N/A | N/A |
| Other Investing Activity | -39,941 | -73,333 | 0 | 0 |
| Investing Cash Flow | $-924,133 | $-752,017 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Dividend Paid | -859,555 | -518,604 | N/A | N/A |
| Other Financing Activity | -75,717 | -96,618 | 0 | 0 |
| Financing Cash Flow | $-935,272 | $-615,222 | $N/A | $N/A |
| Exchange Rate Effect | 10,960 | -8,712 | N/A | N/A |
| Beginning Cash Position | 1,917,045 | 1,351,112 | N/A | N/A |
| End Cash Position | 1,995,930 | 1,876,257 | N/A | N/A |
| Net Cash Flow | $78,894 | $525,145 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 1,927,329 | 1,901,097 | N/A | N/A |
| Capital Expenditure | -536,176 | -487,683 | N/A | N/A |
| Free Cash Flow | 1,391,153 | 1,413,414 | 0 | 0 |